Inactive Instrument

Press Releases Karo Pharma AB (publ)

Equities

KARO

SE0007464888

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Karo Pharma : Michael Kaltenborn appointed CSDO at Karo	23-01-16	PU
Karo Pharma Aktiebolag's application for de-listing has been approved	22-11-10	AQ
Karo Pharma Aktiebolag applies for de-listing	22-11-10	AQ
Karo Intressenter AB initiates compulsory redemption	22-09-26	AQ
Karo Pharma Aktiebolag comments on the public offer from Karo Intressenter AB and obtains a fairness opinion	22-08-26	AQ
Karo Pharma Aktiebolag's board of directors regarding the public offer from Karo Intressenter AB	22-08-17	AQ
Comment from Karo Pharma Aktiebolag's board of directors regarding the public offer from Karo Intressenter AB	22-08-16	AQ
Interim report H1 2022	22-07-21	AQ
Karo Pharma's rights issue fully subscribed	22-04-19	AQ
Karo Pharma publishes the 2021 annual report	22-04-12	AQ
Karo Pharma completes the acquisition of the E45 brand from Reckitt	22-04-04	AQ
Karo Pharma completes the acquisition of the E45® brand from Reckitt	22-04-01	AQ
Karo Pharma publishes prospectus relating to the rights issue and receives approval to change listing venue to Nasdaq First North Growth Market	22-03-23	AQ
Karo Pharma resolves on a fully guaranteed rights issue of approximately SEK 2.5 billion and announces the terms of the rights issue	22-03-16	AQ
Karo Pharma receives approval to delist the Company's share from Nasdaq Stockholm in connection with the change of listing venue to Nasdaq First North Growth Market	22-03-10	AQ
Karo Pharma applies for delisting of the Company's shares from Nasdaq Stockholm, in connection with the change of listing venue to Nasdaq First North Growth Market	22-03-09	AQ
Karo Pharma - Year-end report 2021	22-02-28	AQ
Karo Pharma completes the acquisition of Sylphar International NV	22-01-13	AQ
Karo Pharma enters into an agreement for the potential acquisition of the E45® brand from Reckitt	21-12-24	AQ
Karo Pharma intends to change listing venue to Nasdaq First North Growth Market during the first half of 2022	21-12-15	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Karo Pharma AB (publ)

Equities

KARO

SE0007464888

Press Releases

Filters